UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
Notable Labs, Ltd.
(Name of Issuer)
Ordinary Shares, nominal value of NIS 0.35 per
share
(Title of Class of Securities)
M7517R107
(CUSIP Number)
James Kim
c/o Builders VC
601 California Street, Suite, 700
San Francisco, CA 94108
(415) 692-1720
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
October 16, 2023
(Date of Event which Requires Filing of this
Statement)
If the filing person has previously filed a statement
on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rules 13d-1(e),
13d-1(f) or 13d-1(g), check the following box. ¨
CUSIP No. M7517R107
1 |
NAME OF REPORTING PERSON.
Builders VC Fund I (Canada), L.P. |
2 |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ¨ (b) ¨ |
3 |
SEC USE ONLY
|
4 |
SOURCE OF FUNDS (SEE INSTRUCTIONS)
SC |
5 |
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
¨ |
6 |
CITIZENSHIP OR PLACE OF ORGANIZATION
Alberta, Canada |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
7 |
SOLE VOTING POWER
0 shares |
8 |
SHARED VOTING POWER
305,306 Ordinary Shares
Warrant to purchase up to 4,713 Ordinary Shares |
9 |
SOLE DISPOSITIVE POWER
0 shares |
10 |
SHARED DISPOSITIVE POWER
305,306 Ordinary Shares
Warrant to purchase up to 4,713 Ordinary Shares |
11 |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
305,306 Ordinary Shares
Warrant to purchase up to 4,713 Ordinary Shares |
12 |
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE
INSTRUCTIONS)
¨ |
13 |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11);
3.5%(1) |
14 |
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN |
| (1) | All percentages of ownership of
the Ordinary Shares by Reporting Persons presented in this Statement are based on an aggregate of approximately 8,936,448 Ordinary Shares
issued and outstanding immediately following the consummation of the Merger on October 16, 2023, as set forth in the Issuer’s current
report on Form 8-K, filed on October 16, 2023. |
CUSIP No. M7517R107
1 |
|
NAME OF REPORTING PERSON.
Builders VC Fund I, L.P. |
2 |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ¨ (b) ¨ |
3 |
|
SEC USE ONLY
|
4 |
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
SC |
5 |
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
¨ |
6 |
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
7 |
|
SOLE VOTING POWER
0 shares |
|
8 |
|
SHARED VOTING POWER
1,846,324 Ordinary Shares
Warrant to purchase up to 28,498 Ordinary Shares |
|
9 |
|
SOLE DISPOSITIVE POWER
0 shares |
|
10 |
|
SHARED DISPOSITIVE POWER
1,846,324 Ordinary Shares
Warrant to purchase up to 28,498 Ordinary Shares |
11 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,846,324 Ordinary Shares
Warrant to purchase up to 28,498 Ordinary Shares |
12 |
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
¨ |
13 |
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11);
20.9%(1) |
14 |
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN |
| (1) | All percentages of ownership of
the Ordinary Shares by Reporting Persons presented in this Statement are based on an aggregate of approximately 8,936,448 Ordinary Shares
issued and outstanding immediately following the consummation of the Merger on October 16, 2023, as set forth in the Issuer’s current
report on Form 8-K, filed on October 16, 2023. |
CUSIP No. M7517R107
1 |
|
NAME OF REPORTING PERSON.
Builders VC Entrepreneurs Fund I, L.P. |
2 |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ¨ (b) ¨
|
3 |
|
SEC USE ONLY
|
4 |
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
SC |
5 |
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) or 2(e)
¨
|
6 |
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
7 |
|
SOLE VOTING POWER
0 shares |
|
8 |
|
SHARED VOTING POWER
132,980 Ordinary Shares
Warrant to purchase up to 2,053 Ordinary Shares |
|
9 |
|
SOLE DISPOSITIVE POWER
0 shares |
|
10 |
|
SHARED DISPOSITIVE POWER
132,980 Ordinary Shares
Warrant to purchase up to 2,053 Ordinary Shares |
11 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
132,980 Ordinary Shares
Warrant to purchase up to 2,053 Ordinary Shares |
12 |
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (SEE INSTRUCTIONS)
¨
|
13 |
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11);
1.5%(1) |
14 |
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN |
| (1) | All percentages of ownership of
the Ordinary Shares by Reporting Persons presented in this Statement are based on an aggregate of approximately 8,936,448 Ordinary Shares
issued and outstanding immediately following the consummation of the Merger on October 16, 2023, as set forth in the Issuer’s current
report on Form 8-K, filed on October 16, 2023. |
CUSIP No. M7517R107
1 |
|
NAME OF REPORTING PERSON.
James Jimin Kim |
2 |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) ¨ (b) ¨
|
3 |
|
SEC USE ONLY |
4 |
|
SOURCE OF FUNDS (SEE INSTRUCTIONS)
SC |
5 |
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e)
¨
|
6 |
|
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America |
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
|
7 |
|
SOLE VOTING POWER
0 shares |
|
8 |
|
SHARED VOTING POWER
2,284,610 Ordinary Shares
Warrant to purchase up to 35,264 Ordinary Shares |
|
9 |
|
SOLE DISPOSITIVE POWER
0 shares |
|
10 |
|
SHARED DISPOSITIVE POWER
2,284,610 Ordinary Shares
Warrant to purchase up to 35,264 Ordinary Shares |
11 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,284,610 Ordinary Shares
Warrant to purchase up to 35,264 Ordinary Shares |
12 |
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE
INSTRUCTIONS)
¨ |
13 |
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11);
25.9%(1) |
14 |
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
IN |
| (1) | All percentages of ownership of
the Ordinary Shares by Reporting Persons presented in this Statement are based on an aggregate of approximately 8,936,448 Ordinary Shares
issued and outstanding immediately following the consummation of the Merger on October 16, 2023, as set forth in the Issuer’s current
report on Form 8-K, filed on October 16, 2023. |
CONTINUATION PAGES TO SCHEDULE 13D
This Schedule 13D is being filed by Builders VC
Fund I (Canada), L.P., Builders VC Fund I, L.P., Builders VC Entrepreneurs Fund I, L.P. and James Jimin Kim (collectively, the “Reporting
Persons”, and each, a “Reporting Person”) to report the acquisition of ordinary shares, nominal value of NIS 0.01 per
share (the “Ordinary Shares”), of Notable Labs, Ltd. (the “Issuer”). The address of Builders VC is 601 California
Street, Suite, 700, San Francisco, CA 94108.
Item 1
Security and Issuer
This Schedule 13D relates to the Ordinary Shares
of the Issuer. The address of the Issuer’s principal executive office is: 320 Hatch Drive, Foster City, CA 94404.
Item
2 Identity and Background
Name |
|
Address of
Business/Principal Office |
|
Principal Business/Occupation |
|
Jurisdiction of
Organization/Citizenship |
|
|
|
|
Builders VC Fund I (Canada), L.P. |
|
c/o Builders VC
601 California Street, Suite, 700
San Francisco, CA 94108 |
|
Early stage venture capital firm investing primarily in Series A and seed level companies based in North America. |
|
Alberta, Canada |
|
|
|
|
Builders VC Fund I, L.P. |
|
c/o Builders VC
601 California Street, Suite, 700
San Francisco, CA 94108 |
|
Early stage venture capital firm investing primarily in Series A and seed level companies based in North America. |
|
Delaware |
|
|
|
|
Builders VC Entrepreneurs Fund I, L.P. |
|
c/o Builders VC
601 California Street, Suite, 700
San Francisco, CA 94108 |
|
Early stage venture capital firm investing primarily in Series A and seed level companies based in North America. |
|
Delaware |
|
|
|
|
James Kim |
|
c/o Builders VC
601 California Street, Suite, 700
San Francisco, CA 94108
|
|
Managing member of Builders VC GP I, LLC, the general partner of each of Builders VC Fund I (Canada), L.P., Builders VC Fund I, L.P., Builders VC Entrepreneurs Fund I, L.P., the principal business of which is an early stage venture capital firm investing primarily in Series A and seed level companies based in North America. |
|
United States of America |
The agreement among the Reporting Persons relating
to the joint filing of this Schedule 13D is filed as Exhibit 99.2 hereto.
During the last
five years, none of the Reporting Persons or to the knowledge of the Reporting Persons, any of its affiliates, has been (i) convicted
in a criminal proceeding (excluding traffic violations or similar misdemeanors) or (ii) a party to a civil proceeding of a judicial
or administrative body of competent jurisdiction and as a result of such proceeding has been or is subject to a judgment, decree, or final
order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws, or finding
any violation with respect to such laws.
Item 3
Source and Amount of Funds or Other Consideration
In February 2017, (i) Builders VC Entrepreneurs
Fund I, L.P. purchased 6,653 shares of Notable’s Series A-2 Preferred Stock for an aggregate investment amount of $17,462; (ii)
Builders VC Fund I (Canada), L.P. purchased 15,274 shares of Notable’s Series A-2 Preferred Stock for an aggregate investment amount
of $40,090; and (iii) Builders VC Fund I, L.P. purchased 92,371 shares of Notable’s Series A-2 Preferred Stock for an aggregate
investment amount of $242,448.
In August 2017 and January 2018, (i) Builders
VC Entrepreneurs Fund I, L.P. purchased an aggregate of 99,792 shares of Notable’s Series A-1 Preferred Stock for an aggregate investment
amount of $291,023; (ii) Builders VC Fund I (Canada), L.P. purchased an aggregate of 229,116 shares of Notable’s Series A-1 Preferred
Stock for an aggregate investment amount of $668,171; and (iii) Builders VC Fund I, L.P. purchased an aggregate of 1,385,592 shares of
Notable’s Series A-1 Preferred Stock for an aggregate investment amount of $4,040,802.
In June 2019, (i) Builders VC Entrepreneurs Fund
I, L.P. purchased 38,406 shares of Notable’s Series B Preferred Stock for an aggregate investment amount of $232,821; (ii) Builders
VC Fund I (Canada), L.P. purchased 88,177 shares of Notable’s Series B Preferred Stock for an aggregate investment amount of $534,538;
and (iii) Builders VC Fund I, L.P. purchased 533,254 shares of Notable’s Series B Preferred Stock for an aggregate investment amount
of $3,232,639.
In March and May 2022, (i) Builders VC Entrepreneurs
Fund I, L.P. purchased an aggregate of 15,362 shares of Notable’s Series C-2 Preferred Stock for an aggregate investment amount
of $93,127; (ii) Builders VC Fund I (Canada), L.P. purchased an aggregate of 35,270 shares of Notable’s Series C-2 Preferred Stock
for an aggregate investment amount of $213,812; and (iii) Builders VC Fund I, L.P. purchased an aggregate of 213,301 shares of Notable’s
Series C-2 Preferred Stock for an aggregate investment amount of $1,293,061.
In June 2022, (i) Builders VC Entrepreneurs Fund
I, L.P. purchased 17,267 shares of Notable’s Series C-1 Preferred Stock and a warrant to purchase 32,629 shares of Notable’s
Series C-1 Preferred Stock for an aggregate investment amount of $123,147; (ii) Builders VC Fund I (Canada), L.P. purchased 39,645 shares
of Notable’s Series C-1 Preferred Stock and a warrant to purchase 74,915 shares of Notable’s Series C-1 Preferred Stock for
an aggregate investment amount of $282,744; and (iii) Builders VC Fund I, L.P. purchased 239,753 shares of Notable’s Series C-1
Preferred Stock and a warrant to purchase 453,054 shares of Notable’s Series C-1 Preferred Stock for an aggregate investment amount
of $1,709,894.
In February 2023, (i) Builders VC Entrepreneurs
Fund I, L.P. purchased SAFEs that converted into 1,795,672 shares of Notable’s Series D-1 Preferred Stock for an aggregate investment
amount of $116,590; (ii) Builders VC Fund I (Canada), L.P. purchased SAFEs that converted into 4,122,716 shares of Notable’s Series
D-1 Preferred Stock for an aggregate investment amount of $267,682; and (iii) Builders VC Fund I, L.P. purchased SAFEs that converted
into 24,932,357 shares of Notable’s Series D-1 Preferred Stock for an aggregate investment amount of $1,618,821.
In June 2023, (i) Builders VC Entrepreneurs Fund
I, L.P. purchased SAFEs that converted into 140,917 shares of Notable’s Series D-2 Preferred Stock for an aggregate investment amount
of $116,590; (ii) Builders VC Fund I (Canada), L.P. purchased SAFEs that converted into 323,534 shares of Notable’s Series D-2 Preferred
Stock for an aggregate investment amount of $267,682; and (iii) Builders VC Fund I, L.P. purchased SAFEs that converted into 1,956,592
shares of Notable’s Series D-2 Preferred Stock for an aggregate investment amount of $1,618,821.
On February 22, 2023, Vascular Biogenics Ltd.,
an Israeli corporation (“VBL” or the “Issuer”), Notable Labs, Inc., a Delaware corporation (“Notable”),
and Vibrant Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of VBL (“Merger Sub”), entered into an
Agreement and Plan of Merger dated as of February 22, 2023, as may be amended from time to time (the “Merger Agreement”).
The Merger Agreement contained the terms and conditions of the proposed business combination of VBL and Notable. On October 16, 2023,
pursuant to the Merger Agreement, Merger Sub merged with and into Notable (the “Merger”), with Notable surviving and continuing
as a wholly owned subsidiary of the Issuer, and the Issuer was renamed “Notable Labs, Ltd.” Also on October 16, 2023, in connection
with, and prior to completion of, the Merger, the Issuer effected a 1-for-35 reverse share split (the “Reverse Share Split”)
of its Ordinary Shares. Under the terms of the Merger Agreement, at the effective time of the Merger (the “Effective Time”)
each share of Notable’s common stock outstanding immediately prior to the Effective Time was converted into the right to receive
approximately 0.0629 Ordinary Shares, reflecting adjustment to account for the effect of the Reverse Share Split, and also reflecting
adjustment based on the Issuer Net Cash (as defined in the Merger Agreement) relative to Target Net Cash immediately prior to the closing
of the Merger, and other adjustments. In addition, effective upon the Closing, the holders of unexercised Notable warrants immediately
prior to the Closing were issued replacement warrants to purchase Ordinary Shares.
The foregoing description of the Merger Agreement
does not purport to be complete and is qualified in its entirety by reference to the Merger Agreement. The Merger Agreement was filed
by the Issuer as Exhibit 2.1 to the Issuer’s Form 8-K, as filed with the Securities and Exchange Commission on February 23, 2023.
Item 4
Purpose of Transaction
The information set forth in Items 3 and 6 hereof
is hereby incorporated by reference into this Item 4.
The Reporting Persons who hold securities of the
Issuer directly acquired those shares as an investment in the regular course of their businesses. The Reporting Persons may engage in
discussions with management, the Issuer’s board of directors, other stockholders of the Issuer and other relevant parties concerning
the business, operations, board composition, management, strategy and future plans of the Issuer. The Reporting Persons intend to re-examine
their investment from time to time and, depending on prevailing market conditions, other investment opportunities, liquidity requirements
or other investment considerations the Reporting Persons deem material, the Reporting Persons may from time to time acquire additional
Ordinary Shares in the open market, block trades, negotiated transactions, or otherwise. The Reporting Persons may also dispose of all
or a portion of the Issuer’s securities, in open market or privately negotiated transactions, and/or enter into derivative transactions
with institutional counterparties with respect to the Ordinary Shares, in each case, subject to limitations under applicable law and the
Lock-up Agreement (as defined below).
The Reporting Persons have not yet determined
which, if any, of the above courses of action they may ultimately take. The Reporting Persons’ future actions with regard to the
Issuer are dependent on their evaluation of the factors listed above, circumstances affecting the Issuer in the future, including prospects
of the Issuer, general market and economic conditions and other factors deemed relevant. The Reporting Persons reserve the right to determine
in the future whether to change the purpose or purposes described above or whether to adopt plans or proposals of the type specified above
or otherwise.
Except as set forth above, the Reporting Persons
have no plans or proposals with respect to the Issuer.
Item 5
Interest in Securities of the Issuer
(a) and (b) The responses of each of the
Reporting Persons with respect to Rows 11, 12, and 13 of the cover pages of this Schedule 13D that relate to the aggregate number and
percentage of Ordinary Shares (including but not limited to footnotes to such information) are incorporated herein by reference.
The responses of each of the Reporting Persons
with respect to Rows 7, 8, 9, and 10 of the cover pages of this Schedule 13D that relate to the number of Ordinary Shares as to which
each of the persons or entities referenced in Item 2 above has sole or shared power to vote or to direct the vote of and sole or shared
power to dispose of or to direct the disposition of (including but not limited to footnotes to such information) are incorporated herein
by reference.
132,980 Ordinary Shares and a warrant to purchase
up to 2,053 Ordinary Shares at an exercise price of $113 per share are directly owned by Builders VC Entrepreneurs Fund I, L.P.; 305,306
Ordinary Shares and a warrant to purchase up to 4,713 Ordinary Shares at an exercise price of $113 per share are directly owned by Builders
VC Fund I (Canada), L.P.; and 1,846,324 Ordinary Shares and a warrant to purchase up to 28,498 Ordinary Shares at an exercise price of
$113 per share are owned by Builders VC Fund I, L.P. and each of Builders VC Entrepreneurs Fund I, L.P., Builders VC Fund I (Canada),
L.P. and Builders VC Fund I, L.P (the “Funds”) and Mr. Kim may be deemed to share voting and investment power over the securities
directly held by the Funds because Mr. Kim controls each of the Funds as the managing member of Builders VC GP I, LLC, the general partner
of each of the Funds. Each of the Reporting Persons, and the officers, partners, members and managers thereof, disclaims beneficial ownership
of the securities held directly by the Funds except to the extent of their pecuniary interest therein.
(c) The response to Item 3 is incorporated by
reference herein. Other than as disclosed herein, the Reporting Persons have not effected any transactions in the Ordinary Shares or related
warrants during the past 60 days.
(d) Not applicable.
(e) Not applicable.
Item 6
Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
Lock-up Agreement
In connection with the Merger, the Funds and James
Kim entered into lock-up agreements, dated as of February 22, 2023 (the “Lock-up Agreements”), with the Issuer and Notable.
Pursuant to the Lock-up Agreements, the Funds and Mr. Kim agreed, among other things, to accept certain restrictions on transfers of the
Ordinary Shares held by the Funds for the 60-day period following the closing date of the Merger.
The foregoing description of the Lock-up Agreements
does not purport to be complete and is qualified in its entirety by reference to the form of Lock-up Agreement filed as an exhibit to
the Merger Agreement filed as exhibit 2.1 to the Issuer’s Current Report on Form 8-K filed on February 23, 2023 and incorporated
herein by reference.
Item 7
Materials to Be Filed as Exhibits
SIGNATURE
After reasonable inquiry and to the best of my
knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: October 19, 2023
BUILDERS VC FUND I (CANADA), L.P. |
By: Builders VC GP I, LLC, its general partner |
|
|
|
/s/ James Kim |
|
Name: James Kim |
|
Title: Managing Member |
|
|
BUILDERS VC FUND I, L.P. |
By: Builders VC GP I, LLC, its general partner |
|
|
|
/s/ James Kim |
|
Name: James Kim |
|
Title: Managing Member |
|
|
BUILDERS VC ENTREPRENEURS FUND I, L.P. |
|
|
By: Builders VC GP I, LLC, its general partner |
|
|
|
/s/ James Kim |
|
Name: James Kim |
|
Title: Managing Member |
|
|
|
/s/ James Kim |
|
Name: James Kim |
Exhibit 99.2
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1)
The undersigned acknowledge and agree that the foregoing statement
on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall
be filed on behalf of each of the undersigned without the necessity of filing additional joint filing statements. The undersigned
acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information
concerning him, her or it contained herein, but shall not be responsible for the completeness and accuracy of the information concerning
the other entities or persons, except to the extent that he, she or it knows or has reason to believe that such information is inaccurate.
Date: October 19, 2023
BUILDERS VC FUND I (CANADA), L.P. |
By: Builders VC GP I, LLC, its general partner |
|
|
|
/s/ James Kim |
|
Name: James Kim |
|
Title: Managing Member |
|
|
BUILDERS VC FUND I, L.P. |
By: Builders VC GP I, LLC, its general partner |
|
|
|
/s/ James Kim |
|
Name: James Kim |
|
Title: Managing Member |
|
|
BUILDERS VC ENTREPRENEURS FUND I, L.P. |
|
|
By: Builders VC GP I, LLC, its general partner |
|
|
|
/s/ James Kim |
|
Name: James Kim |
|
Title: Managing Member |
|
|
|
/s/ James Kim |
|
Name: James Kim |
Vascular Biogenics (NASDAQ:VBLT)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
Vascular Biogenics (NASDAQ:VBLT)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025